5 Results for "

ID8

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ID8" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-15838
CAS No.: 147591-46-6
Purity:  99.92%
Target:  

DYRK

Research Areas:  

Cancer

ID-8 is an inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase (DYRK). ID-8 sustains embryonic stem cell (ESC) self-renewal and pluripotency. ID-8 enhances Wnt-mediated hESC survival and proliferation via inhibition of DYRKs .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150231
CAS No.: 2376580-08-2
Purity:  99.77%
Target:  

YB-1

Research Areas:  

Cancer

SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis, and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel (HY-B0015) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13545
CAS No.: 251579-55-2
Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

ABT-510 is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 also reduces angiogenesis and inflammatory responses in a murine model of inflammatory bowel disease. ABT-510 can be used in studies of cancer (particularly epithelial ovarian cancer) and inflammatory bowel disease (IBD) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13545B
CAS No.: 442526-87-6
Purity:  99.61%
Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

ABT-510 acetate is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 acetate also reduces angiogenesis and inflammatory responses in a murine model of inflammatory bowel disease. ABT-510 acetate can be used in studies of cancer (particularly epithelial ovarian cancer) and inflammatory bowel disease (IBD) .
loading...
    loading...
Cat. No.: HY-P991748

Target:  

EGFR ERK

Research Areas:  

Cancer

Anti-Human/Mouse Amphiregulin Antibody (AR37) is an antibody targeting amphiregulin (AREG), with a Kd value of 3.24 nM for the human protein and 6.40 nM for the mouse protein. Anti-Human/Mouse Amphiregulin Antibody (AR37) blocks the autocrine activation of the AREG-EGFR-ERK axis. Anti-Human/Mouse Amphiregulin Antibody (AR37) inhibits the proliferation and migration of ovarian cancer cells. Anti-Human/Mouse Amphiregulin Antibody (AR37) prolongs the survival of immunocompetent mice bearing syngeneic ovarian cancer tumors. Anti-Human/Mouse Amphiregulin Antibody (AR37) is applicable to ovarian cancer-related research .
loading...
    loading...